Neoadjuvant Chemoimmunotherapy or Chemoradiotherapy in ESCC

Clinical trial NCT07385664 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07385664
Sponsor: Ji Yongling
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Resectable Esophageal Cancer

Start date: 2026-01-28
Primary completion: 2027-01-30
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.